Féraille E, Vogt B, Rousselot M, Barlet-Bas C, Cheval L, Doucet A, Favre H
Division de Néphrologie, Hôpital Cantonal Universitaire de Genève, Switzerland.
J Clin Invest. 1993 Apr;91(4):1295-300. doi: 10.1172/JCI116328.
The maximal hydrolytic activity of Na-K-ATPase is specifically increased in the cortical collecting duct (CCD) of rats with puromycin-induced nephrotic syndrome (NS). This stimulation is independent of aldosterone and of endogenous ouabain-like substance. To investigate the mechanism responsible for this change, we compared the maximal Na-K-ATPase hydrolytic activity, the ouabain sensitive 86Rb influx, the specific [3H]ouabain binding, and the sensitivity of Na-K-ATPase to ouabain in the CCD of control rats and of rats given an intraperitoneal injection of puromycin 7 d before study. Both Na-K-ATPase activity and ouabain-sensitive 86Rb influx increased two-fold in rats with NS (ATPase activity: 34.1 +/- 2.1 vs. 18.0 +/- 0.7 pmol.mm-1 x min-1 +/- SE, n = 6, P < 0.001; Rb influx: 14.4 +/- 0.7 vs. 7.4 +/- 0.4 peq.min-1 +/- SE, n = 6, P < 0.001) whereas specific [3H]ouabain binding decreased in rats with NS (6.9 +/- 0.7 vs. 9.0 +/- 0.6 fmol.mm-1 +/- SE, n = 6, P < 0.005). Therefore, the maximal turnover rate of Na-K-ATPase increased over twofold in rats with NS (5,053 +/- 361 vs. 2,043 +/- 124 cycles.min-1 +/- SE, n = 6, P < 0.001). Analysis of the curves of inhibition of Na-K-ATPase by ouabain showed the presence of two Na-K-ATPase populations in both control and NS rats: a highly sensitive population (apparent Ki: 1.4 x 10(-6) M and 0.9 x 10(-6) M) and a less sensitive moiety (apparent Ki: 2.6 x 10(-4) M and 1.1 x 10(-4) M). The enhancement of Na-K-ATPase activity observed in the CCD of rats with NS was entirely due to the stimulation of the population of Na-K-ATPase with low ouabain sensitivity. These results suggest that a dysregulation of this subclass of Na-K-ATPase might be the primary cause of sodium retention in this model of nephrotic syndrome.
在嘌呤霉素诱导的肾病综合征(NS)大鼠的皮质集合管(CCD)中,钠钾ATP酶的最大水解活性特异性增加。这种刺激与醛固酮和内源性哇巴因样物质无关。为了研究导致这种变化的机制,我们比较了对照大鼠和在研究前7天腹腔注射嘌呤霉素的大鼠的CCD中钠钾ATP酶的最大水解活性、哇巴因敏感的86Rb内流、特异性[3H]哇巴因结合以及钠钾ATP酶对哇巴因的敏感性。NS大鼠的钠钾ATP酶活性和哇巴因敏感的86Rb内流均增加了两倍(ATP酶活性:34.1±2.1对18.0±0.7 pmol·mm-1×min-1±SE,n = 6,P < 0.001;Rb内流:14.4±0.7对7.4±0.4 peq·min-1±SE,n = 6,P < 0.001),而NS大鼠的特异性[3H]哇巴因结合减少(6.9±0.7对9.0±0.6 fmol·mm-1±SE,n = 6,P < 0.005)。因此,NS大鼠中钠钾ATP酶的最大周转率增加了两倍多(5,053±361对2,043±124次循环·min-1±SE,n = 6,P < 0.001)。哇巴因对钠钾ATP酶抑制曲线的分析表明,对照大鼠和NS大鼠中均存在两种钠钾ATP酶群体:高敏群体(表观Ki:1.4×10-6 M和0.9×10-6 M)和低敏部分(表观Ki:2.6×10-4 M和1.1×10-4 M)。在NS大鼠的CCD中观察到的钠钾ATP酶活性增强完全是由于对哇巴因敏感性低的钠钾ATP酶群体受到刺激。这些结果表明,这种钠钾ATP酶亚类的失调可能是该肾病综合征模型中钠潴留的主要原因。